Phase I dose of oral quisinostat, in combination with gemcitabine (G) and cisplatin (Cis) or paclitaxel (P) and carboplatin (Carbo) in patients (pts) with non-small cell lung cancer or ovarian cancer (OC)
| Autor: | Mikhail Fedyanin, V. Moiseenko, S. A. Tjulandin, S. Cheporov, Sergey Orlov, Andrew Cakana, V. Azarova, N. Vostokova, O. Karavaeva, V. Vladimirov, G. Manikhas, S. Baranovskiy |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Oncology
medicine.medical_specialty 01 natural sciences chemistry.chemical_compound 0404 agricultural biotechnology Internal medicine medicine Lung cancer Cisplatin business.industry Quisinostat 04 agricultural and veterinary sciences Hematology medicine.disease 040401 food science Carboplatin Gemcitabine 0104 chemical sciences 010404 medicinal & biomolecular chemistry chemistry Paclitaxel Non small cell business Ovarian cancer medicine.drug |
| Zdroj: | Annals of Oncology. 27:vi123 |
| ISSN: | 0923-7534 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|